Literature DB >> 17030820

Myostatin modulates adipogenesis to generate adipocytes with favorable metabolic effects.

Brian J Feldman1, Ryan S Streeper, Robert V Farese, Keith R Yamamoto.   

Abstract

A pluripotent cell line, C3H10T1/2, is induced to undergo adipogenesis by a mixture of factors that includes a glucocorticoid such as dexamethasone. We found that expression of myostatin (MSTN), a TGF-beta family member extensively studied in muscle, was induced by dexamethasone under those differentiation conditions. Moreover, MSTN could substitute for dexamethasone in the adipogenesis mixture. However, the adipocytes induced by MSTN in both cell culture and transgenic mice were small and expressed markers characteristic of immature adipocytes. These adipocytes exhibited cell-autonomous increases in insulin sensitivity and glucose oxidation. In mice, these effects produced elevated systemic insulin sensitivity and resistance to diet-induced obesity. Modulation of the final stages of adipogenesis may provide a novel approach to understanding and treating metabolic disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17030820      PMCID: PMC1592529          DOI: 10.1073/pnas.0607501103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

1.  Characterization of 5'-regulatory region of human myostatin gene: regulation by dexamethasone in vitro.

Authors:  K Ma; C Mallidis; J Artaza; W Taylor; N Gonzalez-Cadavid; S Bhasin
Journal:  Am J Physiol Endocrinol Metab       Date:  2001-12       Impact factor: 4.310

Review 2.  Adipogenesis: forces that tip the scales.

Authors:  Ormond A MacDougald; Susanne Mandrup
Journal:  Trends Endocrinol Metab       Date:  2002 Jan-Feb       Impact factor: 12.015

Review 3.  Adipose tissue as an endocrine organ.

Authors:  Erin E Kershaw; Jeffrey S Flier
Journal:  J Clin Endocrinol Metab       Date:  2004-06       Impact factor: 5.958

4.  Powerful genes--myostatin regulation of human muscle mass.

Authors:  Elizabeth M McNally
Journal:  N Engl J Med       Date:  2004-06-24       Impact factor: 91.245

5.  Suppression of oxidative metabolism and mitochondrial biogenesis by the transcriptional corepressor RIP140 in mouse adipocytes.

Authors:  Aimee M Powelka; Asha Seth; Joseph V Virbasius; Evangelos Kiskinis; Sarah M Nicoloro; Adilson Guilherme; Xiaoqing Tang; Juerg Straubhaar; Andrew D Cherniack; Malcolm G Parker; Michael P Czech
Journal:  J Clin Invest       Date:  2005-12-22       Impact factor: 14.808

6.  Inhibition of preadipocyte differentiation by myostatin treatment in 3T3-L1 cultures.

Authors:  H S Kim; L Liang; R G Dean; D B Hausman; D L Hartzell; C A Baile
Journal:  Biochem Biophys Res Commun       Date:  2001-03-09       Impact factor: 3.575

7.  Myostatin knockout in mice increases myogenesis and decreases adipogenesis.

Authors:  Ji Lin; Heather B Arnold; Mary Anne Della-Fera; Michael J Azain; Diane L Hartzell; Clifton A Baile
Journal:  Biochem Biophys Res Commun       Date:  2002-03-01       Impact factor: 3.575

8.  Suppression of body fat accumulation in myostatin-deficient mice.

Authors:  Alexandra C McPherron; Se-Jin Lee
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

9.  A Mediator subunit, MDT-15, integrates regulation of fatty acid metabolism by NHR-49-dependent and -independent pathways in C. elegans.

Authors:  Stefan Taubert; Marc R Van Gilst; Malene Hansen; Keith R Yamamoto
Journal:  Genes Dev       Date:  2006-05-01       Impact factor: 11.361

10.  Need for GLUT4 activation to reach maximum effect of insulin-mediated glucose uptake in brown adipocytes isolated from GLUT4myc-expressing mice.

Authors:  Daniel Konrad; Philip J Bilan; Zafar Nawaz; Gary Sweeney; Wenyan Niu; Zhi Liu; Costin N Antonescu; Assaf Rudich; Amira Klip
Journal:  Diabetes       Date:  2002-09       Impact factor: 9.461

View more
  82 in total

1.  Functional analysis of pig myostatin gene promoter with some adipogenesis- and myogenesis-related factors.

Authors:  Bing Deng; Jianghui Wen; Yi Ding; Qishuang Gao; Haijun Huang; Zhiping Ran; Yunguo Qian; Jian Peng; Siwen Jiang
Journal:  Mol Cell Biochem       Date:  2011-12-11       Impact factor: 3.396

Review 2.  Muscles, exercise and obesity: skeletal muscle as a secretory organ.

Authors:  Bente K Pedersen; Mark A Febbraio
Journal:  Nat Rev Endocrinol       Date:  2012-04-03       Impact factor: 43.330

3.  METABOLIC FUNCTIONS OF MYOSTATIN AND GDF11.

Authors:  Alexandra C McPherron
Journal:  Immunol Endocr Metab Agents Med Chem       Date:  2010-12

Review 4.  The influence of skeletal muscle on systemic aging and lifespan.

Authors:  Fabio Demontis; Rosanna Piccirillo; Alfred L Goldberg; Norbert Perrimon
Journal:  Aging Cell       Date:  2013-07-17       Impact factor: 9.304

5.  Glucocorticoids influence on mesenchymal stem cells and implications for metabolic disease.

Authors:  Brian J Feldman
Journal:  Pediatr Res       Date:  2009-02       Impact factor: 3.756

6.  Inhibition of myostatin protects against diet-induced obesity by enhancing fatty acid oxidation and promoting a brown adipose phenotype in mice.

Authors:  C Zhang; C McFarlane; S Lokireddy; S Masuda; X Ge; P D Gluckman; M Sharma; R Kambadur
Journal:  Diabetologia       Date:  2011-09-17       Impact factor: 10.122

Review 7.  Beyond the bone: Bone morphogenetic protein signaling in adipose tissue.

Authors:  Ana M Blázquez-Medela; Medet Jumabay; Kristina I Boström
Journal:  Obes Rev       Date:  2019-01-04       Impact factor: 9.213

8.  The effects of myostatin on adipogenic differentiation of human bone marrow-derived mesenchymal stem cells are mediated through cross-communication between Smad3 and Wnt/beta-catenin signaling pathways.

Authors:  Wen Guo; John Flanagan; Ravi Jasuja; James Kirkland; Lan Jiang; Shalender Bhasin
Journal:  J Biol Chem       Date:  2008-01-18       Impact factor: 5.157

9.  Genetic disruption of myostatin reduces the development of proatherogenic dyslipidemia and atherogenic lesions in Ldlr null mice.

Authors:  Powen Tu; Shalender Bhasin; Paul W Hruz; Karen L Herbst; Lawrence W Castellani; Ning Hua; James A Hamilton; Wen Guo
Journal:  Diabetes       Date:  2009-06-09       Impact factor: 9.461

10.  Myostatin inhibition in muscle, but not adipose tissue, decreases fat mass and improves insulin sensitivity.

Authors:  Tingqing Guo; William Jou; Tatyana Chanturiya; Jennifer Portas; Oksana Gavrilova; Alexandra C McPherron
Journal:  PLoS One       Date:  2009-03-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.